Practice
Aminoglycoside-induced ototoxicity
Jerome A. Leis, John A. Rutka and Wayne L. Gold
CMAJ January 06, 2015 187 (1) E52; DOI: https://doi.org/10.1503/cmaj.140339
Jerome A. Leis
Division of Infectious Diseases (Leis, Gold), Department of Medicine; Centre for Quality Improvement and Patient Safety (Leis); Department of Otolaryngology — Head and Neck Surgery (Rutka), University of Toronto, Toronto, Ont.
MD MScJohn A. Rutka
Division of Infectious Diseases (Leis, Gold), Department of Medicine; Centre for Quality Improvement and Patient Safety (Leis); Department of Otolaryngology — Head and Neck Surgery (Rutka), University of Toronto, Toronto, Ont.
MDWayne L. Gold
Division of Infectious Diseases (Leis, Gold), Department of Medicine; Centre for Quality Improvement and Patient Safety (Leis); Department of Otolaryngology — Head and Neck Surgery (Rutka), University of Toronto, Toronto, Ont.
MD![Loading Loading](https://www.cmaj.ca/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Article Figures & Tables
There are no figures or tables available.
In this issue
Article tools
Respond to this article
Aminoglycoside-induced ototoxicity
Jerome A. Leis, John A. Rutka, Wayne L. Gold
CMAJ Jan 2015, 187 (1) E52; DOI: 10.1503/cmaj.140339
Jump to section
- Article
- Aminoglycoside-induced ototoxicity can profoundly affect quality of life
- Aminoglycoside-induced ototoxicity is often preventable
- Discontinuation of aminoglycoside therapy at the earliest recognition of ototoxicity may reduce the extent of impairment
- Normal laboratory monitoring may provide false reassurance
- Patients must be counselled regarding the risks and benefits of aminoglycoside therapy
- Footnotes
- References
- Figures & Tables
- Related Content
- Responses
- Metrics